David McCormick, Ph.D.
Professor of BiologySenior Vice President and Director, IIT Research Institute
Office: IITRI LSR 1A1-1
Office Hours:
Phone: 312.567.4972
Fax: 312.567.4021
Email:
dmccormick@iitri.org
Web:
Expertise
Education
- B.A, Middlebury College
- Ph.D, New York University
Curriculum Vitae
Research & Major Accomplishments
- natural and synthetic analogs of vitamin A (retinoids), currently focusing on ligands for the Retinoid X Receptor (RXR)
- inhibitors of the cyclooxygenase and lipoxygenase pathways of arachidonic acid metabolism, currently focusing on inhibitors of cyclooxygenase-2 (COX-2)
- hormones and antihormones
- natural products, including soy isoflavones and polyphenols isolated from green tea.
Our laboratory has also played a significant role in optimizing site-specific animal models for studies of cancer prevention. This work has included characterization of dose- and time-response relationships for neoplastic development, modification of carcinogen exposure regimens to optimize organ-specific cancer induction, and studies of molecular mechanisms and biomarkers of carcinogenesis.
We have long-standing collaborations in the fields of cancer prevention and therapy with scientists at the National Cancer Institute, as well as with faculty at New York University School of Medicine (prostate carcinogenesis) and Ohio State University (lung carcinogenesis and molecular biomarkers). Current research support includes 1 research grant and 11 research contracts from the National Cancer Institute, and 1 research contract from the National Institute of Environmental Health Sciences.
Research in areas other than cancer prevention and therapy includes studies to evaluate the possible health effects of non-ionizing radiation (radiofrequency [cell phone] and 60 Hz [power frequency] magnetic fields), preclinical safety assessments of novel therapeutics, and studies in the general area of environmental toxicology.
Current Projects
Awards/Honors
Patents
Books
Selected Publications
- "Chemoprevention of rat prostate carcinogenesis by 16alpha-fluoro-5-androsten-17-one (fluasterone), a minimally androgenic analog of dehydroepiandrosterone". Carcinogenesis, 28: 398-403, 2007. D. L. McCormick, W. D. Johnson, N. M. Kozub, K. V. N. Rao, R. A. Lubet, V. E. Steele, and M. C. Bosland.
- "Oncogenicity Evaluations of Chemopreventive Soy Components in p53(+/-) (p53 knockout) Mice". Int. J. Toxicol., 25: 219-228, 2006. W. D. Johnson, L. Dooley, R. L. Morrissey, L. Arp, I. Kapetanovic, J. A. Crowell, and D. L. McCormick.
- "Evaluation of the Toxicity and Potential Oncogenicity of ELF Magnetic Fields in Experimental Animal Model Systems. In: B. Greenebaum and F. Barnes (eds.), Handbook of Biological Effects of Electromagnetic Fields, 3rd Edition. CRC Press, pp. 21-52, 2006.
- "Modulation of Hepatic and Renal Drug Metabolizing Enzyme Systems in Rats by Subchronic Administration of Farnesol". Chem. Biol. Interact., 252: 79-99, 2005. T. L. Horn, L. Long, M. J. Cwik, R. L. Morrissey, I. M. Kapetanovic, and D. L. McCormick.
- "Animal Models for the Study of Childhood Leukemia: Considerations for Model Identification and Optimization to Identify Potential Risk Factors". Int. J. Toxicol., 23: 149-161, 2004. D. L. McCormick and R. Kavet. [Winner of the 2004 "Best Paper" Award from the American College of Toxicology]
